151 related articles for article (PubMed ID: 22655084)
1. Combination of RGD compound and low-dose paclitaxel induces apoptosis in human glioblastoma cells.
Chang MW; Lo JM; Juan HF; Chang HY; Chuang CY
PLoS One; 2012; 7(5):e37935. PubMed ID: 22655084
[TBL] [Abstract][Full Text] [Related]
2. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
3. Co-delivery of TRAIL gene enhances the anti-glioblastoma effect of paclitaxel in vitro and in vivo.
Zhan C; Wei X; Qian J; Feng L; Zhu J; Lu W
J Control Release; 2012 Jun; 160(3):630-6. PubMed ID: 22410115
[TBL] [Abstract][Full Text] [Related]
4. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
5. A pH-responsive cell-penetrating peptide-modified liposomes with active recognizing of integrin αvβ3 for the treatment of melanoma.
Shi K; Li J; Cao Z; Yang P; Qiu Y; Yang B; Wang Y; Long Y; Liu Y; Zhang Q; Qian J; Zhang Z; Gao H; He Q
J Control Release; 2015 Nov; 217():138-50. PubMed ID: 26368312
[TBL] [Abstract][Full Text] [Related]
6. Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy.
Babu A; Amreddy N; Muralidharan R; Pathuri G; Gali H; Chen A; Zhao YD; Munshi A; Ramesh R
Sci Rep; 2017 Nov; 7(1):14674. PubMed ID: 29116098
[TBL] [Abstract][Full Text] [Related]
7. Fluorescent RGD-based pro-apoptotic peptide conjugates as mitochondria-targeting probes for enhanced anticancer activities.
Rizvi SFA; Mu S; Wang Y; Li S; Zhang H
Biomed Pharmacother; 2020 Jul; 127():110179. PubMed ID: 32387862
[TBL] [Abstract][Full Text] [Related]
8. Integrin-facilitated transcytosis for enhanced penetration of advanced gliomas by poly(trimethylene carbonate)-based nanoparticles encapsulating paclitaxel.
Jiang X; Sha X; Xin H; Xu X; Gu J; Xia W; Chen S; Xie Y; Chen L; Chen Y; Fang X
Biomaterials; 2013 Apr; 34(12):2969-79. PubMed ID: 23380351
[TBL] [Abstract][Full Text] [Related]
9. Radiochemical Evaluation and
Karimi H; Sadeghzadeh N; Abediankenari S; Rezazadeh F; Hallajian F
Curr Radiopharm; 2017 Aug; 10(2):139-144. PubMed ID: 28681701
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-loaded multifunctional nanoparticles for the targeted treatment of glioblastoma.
Ganipineni LP; Ucakar B; Joudiou N; Riva R; Jérôme C; Gallez B; Danhier F; Préat V
J Drug Target; 2019; 27(5-6):614-623. PubMed ID: 30633585
[TBL] [Abstract][Full Text] [Related]
11. Paclitaxel and naringenin-loaded solid lipid nanoparticles surface modified with cyclic peptides with improved tumor targeting ability in glioblastoma multiforme.
Wang L; Wang X; Shen L; Alrobaian M; Panda SK; Almasmoum HA; Ghaith MM; Almaimani RA; Ibrahim IAA; Singh T; Baothman AA; Choudhry H; Beg S
Biomed Pharmacother; 2021 Jun; 138():111461. PubMed ID: 33706131
[TBL] [Abstract][Full Text] [Related]
12. αVβ3 Integrin-Targeted Radionuclide Therapy with 64Cu-cyclam-RAFT-c(-RGDfK-)4.
Jin ZH; Furukawa T; Degardin M; Sugyo A; Tsuji AB; Yamasaki T; Kawamura K; Fujibayashi Y; Zhang MR; Boturyn D; Dumy P; Saga T
Mol Cancer Ther; 2016 Sep; 15(9):2076-85. PubMed ID: 27422811
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor effect of integrin targeted (177)Lu-3PRGD2 and combined therapy with Endostar.
Shi J; Fan D; Dong C; Liu H; Jia B; Zhao H; Jin X; Liu Z; Li F; Wang F
Theranostics; 2014; 4(3):256-66. PubMed ID: 24505234
[TBL] [Abstract][Full Text] [Related]
14. Synergistic targeting tenascin C and neuropilin-1 for specific penetration of nanoparticles for anti-glioblastoma treatment.
Kang T; Zhu Q; Jiang D; Feng X; Feng J; Jiang T; Yao J; Jing Y; Song Q; Jiang X; Gao X; Chen J
Biomaterials; 2016 Sep; 101():60-75. PubMed ID: 27267628
[TBL] [Abstract][Full Text] [Related]
15. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.
Jiang X; Sha X; Xin H; Chen L; Gao X; Wang X; Law K; Gu J; Chen Y; Jiang Y; Ren X; Ren Q; Fang X
Biomaterials; 2011 Dec; 32(35):9457-69. PubMed ID: 21911250
[TBL] [Abstract][Full Text] [Related]
16. A small-molecule RGD-integrin antagonist inhibits cell adhesion, cell migration and induces anoikis in glioblastoma cells.
Russo MA; Paolillo M; Sanchez-Hernandez Y; Curti D; Ciusani E; Serra M; Colombo L; Schinelli S
Int J Oncol; 2013 Jan; 42(1):83-92. PubMed ID: 23174862
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of RGD peptidomimetic-paclitaxel conjugates bearing lysosomally cleavable linkers.
Dal Corso A; Caruso M; Belvisi L; Arosio D; Piarulli U; Albanese C; Gasparri F; Marsiglio A; Sola F; Troiani S; Valsasina B; Pignataro L; Donati D; Gennari C
Chemistry; 2015 Apr; 21(18):6921-9. PubMed ID: 25784522
[TBL] [Abstract][Full Text] [Related]
18. RGD-based strategies for improving antitumor activity of paclitaxel-loaded liposomes in nude mice xenografted with human ovarian cancer.
Zhao H; Wang JC; Sun QS; Luo CL; Zhang Q
J Drug Target; 2009 Jan; 17(1):10-8. PubMed ID: 19016068
[TBL] [Abstract][Full Text] [Related]
19. Precise glioblastoma targeting by AS1411 aptamer-functionalized poly (l-γ-glutamylglutamine)-paclitaxel nanoconjugates.
Luo Z; Yan Z; Jin K; Pang Q; Jiang T; Lu H; Liu X; Pang Z; Yu L; Jiang X
J Colloid Interface Sci; 2017 Mar; 490():783-796. PubMed ID: 27988470
[TBL] [Abstract][Full Text] [Related]
20. Tumor uptake of the RGD dimeric probe (99m)Tc-G3-2P4-RGD2 is correlated with integrin αvβ3 expressed on both tumor cells and neovasculature.
Liu Z; Jia B; Shi J; Jin X; Zhao H; Li F; Liu S; Wang F
Bioconjug Chem; 2010 Mar; 21(3):548-55. PubMed ID: 20184307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]